Actively Recruiting
Identification of Genetic Variants Associated With Unexpected Infant Death Syndrome
Led by Nantes University Hospital · Updated on 2026-05-08
650
Participants Needed
15
Research Sites
165 weeks
Total Duration
On this page
Sponsors
N
Nantes University Hospital
Lead Sponsor
A
AXA Assurances VIE Mutuelle
Collaborating Sponsor
AI-Summary
What this Trial Is About
This is a multicenter genetic study aimed at identifying new genes/variants associated with sudden infant death syndrome (SIDS) based on whole-genome sequencing of family trios
CONDITIONS
Official Title
Identification of Genetic Variants Associated With Unexpected Infant Death Syndrome
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Child aged 0 to 2 years who died from sudden unexpected infant death
- Child is included in the French SUDI registry with participation in the biocollection
- Child meets inclusion criteria for BIOMINRISK-NEUROBIO and BIOMINRISK-RADIO-ANAT studies
- Biological parents of the child are included in the BIOMINRISK study
- Parents have signed consent for blood collection and sample inclusion in the biocollection
- Parents have social security or similar health coverage
You will not qualify if you...
- Child had a known metabolic, genetic, or syndromic disease at time of death
- Parent is under guardianship
- Parent has a known metabolic, genetic, or syndromic disease
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 15 locations
1
Nantes University Hospital
Nantes, Loire-Atlantique, France, 44093
Actively Recruiting
2
CHU Amiens
Amiens, France
Actively Recruiting
3
CHU Angers
Angers, France
Actively Recruiting
4
CHU Besançon
Besançon, France
Actively Recruiting
5
APHP - Hôpital Jean Verdier
Bondy, France
Actively Recruiting
6
CHU Brest
Brest, France
Actively Recruiting
7
APHP - Hôpital Antoine Béclère
Clamart, France
Actively Recruiting
8
CHU Grenoble
Grenoble, France
Actively Recruiting
9
HCL
Lyon, France
Actively Recruiting
10
AP-HM
Marseille, France
Not Yet Recruiting
11
CHU Montpellier
Montpellier, France
Actively Recruiting
12
CHRU Nancy
Nancy, France
Actively Recruiting
13
CHU Rouen
Rouen, France
Actively Recruiting
14
CHU Saint Etienne
Saint-Etienne, France
Actively Recruiting
15
CHU Toulouse
Toulouse, France
Actively Recruiting
Research Team
F
Fleur Lorton
CONTACT
A
Alban-Elouen BARUTEAU
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here